Stock Alert: Inovio Pharma Plummets 30% As FDA Puts On Hold Its Coronavirus Vaccine

Shares of Inovio Pharmaceuticals, Inc. (INO) tanked 30% on Monday morning after the biotechnology company announced that phase 2/3 trial of its COVID-19 vaccine candidate will be delayed after the U.S. FDA put it on hold.